Juliana Gonçalves Moraes

Responsible for leading the transformation of the patient journey within the Immunology therapeutic area through a consultative, functionally agnostic approach (bridging Medical Affairs and Commercial strategy). Key activities include:
- Ecosystem Mapping & Strategy: Aligning diverse healthcare stakeholders and resources to dismantle systemic barriers, accelerate diagnosis, and streamline patient access to treatments.
- Value-Based Healthcare (VBHC): Identifying unmet medical needs to co-create sustainable, high-impact solutions that deliver faster and better outcomes for patients and the health ecosystem.
- Scientific Partnership: Acting as the primary point of contact for the Brazilian scientific community to drive scientific exchanges, medical education initiatives, and peer-to-peer collaborations.
- Cross-functional Collaboration: Interfacing with Medical, Scientific Communications, and Digital teams to synchronize resources, maximize synergies, and scale local insights globally.
- Strategic Decision-Making: Utilizing system-thinking autonomy to mobilize corporate networks and allocate resources effectively for maximum ecosystem impact.
- Governance: Ensuring the ethical and balanced use of innovative therapies while maintaining impeccable scientific credibility across all interactions.

Responsible for preparing the healthcare ecosystem for the launch of an innovative therapy for Paroxysmal Nocturnal Hemoglobinuria (PNH), acting cross-functionally to support patient journey optimization and treatment access.

• Evaluates market conditions and performance, providing insightful analysis to drive strategic decisions.
• Develops projections for market penetration and sales, contributing to accurate company forecasts.
• Constructs a comprehensive Marketing Plan grounded in commitment, expertise, environmental analysis, and customer perception.
• Collaborates with cross-functional teams to develop and communicate strategies and tactical plans to the sales force for more successful implementation.
• In-depth knowledge of Orphan diseases market dynamics and reimbursement intricacies.
• Proven ability to establish and maintain strong relationships with key opinion leaders in Human Genetics and Bone Health.

• Identify Key Opinion Leaders (KOLs), and establish and maintain scientific relationships with KOLs; connecting to KOLs in academic and community centers.
• Act as primary liaison to investigators interested in developing and performing investigator initiated research.
• Develop and execute territory plans in alignment with company plans.
• Collaborate with the Clinical Operations organization to enhance patient enrolment in company-sponsored clinical trials by identifying appropriate clinical trial sites and interacting with investigators in ongoing studies.
• Provide scientific and medical information updates and scientific support at medical congresses and educational initiatives.
• Provide timely feedback/information on emerging clinical/scientific teams and opportunities to internal stakeholders.

• Develop and maintain relationship with Key Opinion Leaders (KOLs).
• Launch of the first Biosimilar mAb in Brazil (Remsima - infliximab), through scientific work and educational activities with KOLs (rheumatology, dermatology and gastroenterology).
• Identify and create local opportunities for company product development.
• Deliver training and provide support to the Marketing and Sales Department in Scientific and Technical area.
• Review scientific articles and training material.
• Provide field-based clinical support to customers by educational presentations, responding to unsolicited medical information requests.
• Participation and interaction on continuing educational Congresses, Workshops and Seminars.